Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hong Kong, Macao Block Use Of Allopurinol After Five Deaths

This article was originally published in PharmAsia News

Executive Summary

Macao and Hong Kong authorities have taken action against the allopurinol gout drug made by Europharm Laboratories following five death reports. Macao ordered the drug recalled and imports blocked while Hong Kong SAR's Health Department urged a halt to use of the drug. Batches made by the Hong Kong-based pharma were discovered to have been tainted with fungal contamination. Health authorities in Hong Kong, where about 40,000 patients have received the drug, said they found a bacteria mucormycosis level in some batches 100 times more than the standard amount. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts